A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 244,154 shares of ARCT stock, worth $5.38 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
244,154
Previous 244,154 -0.0%
Holding current value
$5.38 Million
Previous $5.95 Million -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$24.35 - $44.39 $2.22 Million - $4.05 Million
-91,224 Reduced 27.2%
244,154 $5.95 Million
Q1 2024

May 15, 2024

BUY
$31.23 - $42.99 $9.92 Million - $13.7 Million
317,800 Added 1807.94%
335,378 $11.3 Million
Q4 2023

Feb 14, 2024

SELL
$17.71 - $32.97 $5.63 Million - $10.5 Million
-317,700 Reduced 94.76%
17,578 $554,000
Q3 2023

Nov 14, 2023

BUY
$25.44 - $37.35 $8.42 Million - $12.4 Million
330,875 Added 7514.76%
335,278 $8.57 Million
Q2 2023

Aug 14, 2023

SELL
$23.94 - $32.36 $1.82 Million - $2.46 Million
-75,985 Reduced 94.52%
4,403 $126,000
Q1 2023

May 15, 2023

BUY
$14.72 - $23.97 $233,871 - $380,835
15,888 Added 24.63%
80,388 $1.93 Million
Q4 2022

Feb 14, 2023

SELL
$14.14 - $23.06 $7.81 Million - $12.7 Million
-552,624 Reduced 89.55%
64,500 $1.09 Million
Q3 2022

Nov 14, 2022

SELL
$13.05 - $22.13 $3.87 Million - $6.55 Million
-296,199 Reduced 32.43%
617,124 $9.15 Million
Q2 2022

Aug 15, 2022

BUY
$12.26 - $31.17 $5.98 Million - $15.2 Million
488,123 Added 114.8%
913,323 $14.4 Million
Q1 2022

May 16, 2022

BUY
$17.64 - $39.57 $7.5 Million - $16.8 Million
425,200 New
425,200 $11.5 Million
Q3 2020

Nov 16, 2020

SELL
$37.49 - $63.19 $8.36 Million - $14.1 Million
-223,013 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$12.66 - $58.27 $2.82 Million - $13 Million
223,013 New
223,013 $10.4 Million

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $585M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.